rxstatShortages › Nifedipine

Nifedipine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Nifedipine products are in shortage in Canada (3 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
3 / 16
In shortage since
Mar 10, 2017
Reports on file
60
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MYLAN-NIFEDIPINE EXTENDED RELEASE
30MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02349167 · since Jun 2, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-NIFED PA - SRT 20MG
20MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02181525 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-NIFED PA - TAB 10MG
10MG · TABLET · APOTEX INC
DIN 02197448 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
MYLAN-NIFEDIPINE EXTENDED RELEASE
30MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02349167 · ended May 25, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP NIFEDIPINE ER
60MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02511711 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Discontinued
NIFEDIPINE ER
30MG · TABLET (EXTENDED-RELEASE) · PRO DOC LIMITEE
DIN 02421631
Resolved
MYLAN-NIFEDIPINE EXTENDED RELEASE
30MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02349167 · ended Nov 7, 2023 · Disruption of the manufacture of the drug.
Avoided
NIFEDIPINE
5MG · CAPSULE · AA PHARMA INC
DIN 00725110 · ended Jul 27, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
10MG · CAPSULE · AA PHARMA INC
DIN 00755907 · ended Jul 27, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
5MG · CAPSULE · AA PHARMA INC
DIN 00725110 · ended May 30, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
10MG · CAPSULE · AA PHARMA INC
DIN 00755907 · ended Feb 10, 2023 · Disruption of the manufacture of the drug.
Resolved
PMS-NIFEDIPINE ER
30MG · TABLET (EXTENDED-RELEASE) · PHARMASCIENCE INC
DIN 02418630 · ended Jan 25, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Nifedipine is currently affected by 3 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Nifedipine is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.” (ATC C08CA).

Recent changes

Common questions

When will Nifedipine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Nifedipine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (selective calc.channel block. w/mainly vasc. eff.)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.